ULURU Inc. reported earnings results for the third quarter and nine months ended September 30, 2015. For the quarter, the company's revenues were $24,799 against $322,783 a year ago. The net decrease of $298,000 in revenues is attributable to a decrease of $274,000 in Altrazeal® product sales to international distributors and a decrease of $24,000 in royalties from the international distributors. Operating loss was $815,517 against $641,760 a year ago. Loss before income taxes was $866,090 compared to $678,859 a year ago. Net loss was $866,090 or $0.03 per share compared to $678,859 or $0.03 per share a year ago.

For the nine months, the company's revenues were $578,444 against $634,058 a year ago. The net decrease of $56,000 in revenues is attributable to a decrease of $17,000 in Altrazeal® product sales to international distributors and a decrease of $41,000 in royalties from the international distributors; which were partially offset by an increase of $2,000 in license fees related to Altrazeal®. Operating loss was $2,149,522 against $2,092,717 a year ago. Loss before income taxes was $2,333,742 compared to $2,256,865 a year ago. Net loss was $2,333,742 or $0.09 per share compared to $2,256,865 or $0.10 per share a year ago.